2nd COVID-19 vaccine trial paused over unexplained illness
Share
Tweet
October 13, 2020
Cheryl Gerber – Associated Press
This September 2020 photo provided by Johnson & Johnson shows a single-dose COVID-19 vaccine being developed by the company. A late-stage study of Johnson & Johnson's COVID-19 vaccine candidate has been paused while the company investigates whether a study participant's "unexplained illness" is related to the shot, the company announced Monday, Oct. 12, 2020.
NEW BRUNSWICK, N.J. - A late-stage study of Johnson & Johnson's COVID-19 vaccine candidate has been paused while the company investigates whether a study participant's "unexplained illness" is related to the shot.
The company said in a statement Monday evening that illnesses, accidents and other so-called adverse events "are an expected part of any clinical study, especially large studies," but that its physicians and a safety monitoring panel would try to determine what might have caused the illness.
The pause is at least the second such hold to occur among several vaccines that have reached large-scale final tests in the U.S.
https://www.startribune.com/2nd-covid-19-vaccine-trial-paused-over-unexplained-illness/572721411/
Reader Comments(0)